Cargando…

Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer

Detalles Bibliográficos
Autores principales: Lin, Zhihuan, Zhang, Yaxiong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427306/
https://www.ncbi.nlm.nih.gov/pubmed/32639662
http://dx.doi.org/10.1002/cac2.12070
_version_ 1783570852821860352
author Lin, Zhihuan
Zhang, Yaxiong
Zhang, Li
author_facet Lin, Zhihuan
Zhang, Yaxiong
Zhang, Li
author_sort Lin, Zhihuan
collection PubMed
description
format Online
Article
Text
id pubmed-7427306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74273062020-08-16 Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer Lin, Zhihuan Zhang, Yaxiong Zhang, Li Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2020-07-08 /pmc/articles/PMC7427306/ /pubmed/32639662 http://dx.doi.org/10.1002/cac2.12070 Text en © 2020 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Lin, Zhihuan
Zhang, Yaxiong
Zhang, Li
Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
title Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
title_full Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
title_fullStr Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
title_full_unstemmed Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
title_short Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
title_sort construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427306/
https://www.ncbi.nlm.nih.gov/pubmed/32639662
http://dx.doi.org/10.1002/cac2.12070
work_keys_str_mv AT linzhihuan constructionofanintegratedprognosticclassifiermodelforpredictingtheefficacyofimmunecheckpointinhibitortherapyinnonsmallcelllungcancer
AT zhangyaxiong constructionofanintegratedprognosticclassifiermodelforpredictingtheefficacyofimmunecheckpointinhibitortherapyinnonsmallcelllungcancer
AT zhangli constructionofanintegratedprognosticclassifiermodelforpredictingtheefficacyofimmunecheckpointinhibitortherapyinnonsmallcelllungcancer